Condition
Transthyretin Amyloidosis With Cardiomyopathy clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Transthyretin Amyloidosis With Cardiomyopathy clinical trials that are recruiting, at sites in 36 countries (most in Germany (3), Japan (2), United States (2)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 36Countries
Newest Transthyretin Amyloidosis With Cardiomyopathy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Long-term safety of eplontersen in adults with transthyretin amyloidosis, including those with prior liver transplant or severe liver impairment | — | Los Angeles, California and 5 other locations | Recruiting | Jun 17, 2026 |
| Long-term global follow-up of adults with ATTR-CM treated with vutrisiran or other approved therapies | — | Tucson, Arizona and 26 other locations | Recruiting | Jan 22, 2026 |
| Nucresiran for transthyretin amyloidosis with cardiomyopathy | Phase 3 | La Jolla, California and 265 other locations | Recruiting | Jul 8, 2025 |
All recruiting trials (3)
-
Long-term safety of eplontersen in adults with transthyretin amyloidosis, including those with prior liver transplant or severe liver impairment
This study will see if eplontersen remains safe over time for adults with transthyretin amyloidosis, including people who have had a liver transplant or have severe liver problems.
-
Long-term global follow-up of adults with ATTR-CM treated with vutrisiran or other approved therapies
This project will follow adults with ATTR-CM who start vutrisiran or another approved treatment to see how they do over up to five years in routine clinical care.
-
Nucresiran for transthyretin amyloidosis with cardiomyopathy
This trial will test whether nucresiran can lower deaths and major heart-related events in people with transthyretin amyloidosis that affects the heart.
Related topics
Quick answers
How many Transthyretin Amyloidosis With Cardiomyopathy clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 36 countries. The most sites are in Germany (3 trials), Japan (2 trials), United States (2 trials), Canada (2 trials), China (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.